Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Two Genes Appear to Act as On/Off Switches for Neuroinflammation and Alzheimer’s Disease

Researchers with Massachusetts General Hospital have identified some crosstalk communication between TREM2 and CD33, two genes that play a role in inflammation and Alzheimer’s disease.

Read More »

Study Shows Hospitals Significantly Hike Drug Prices

A study commissioned by Pharmaceutical Research and Manufacturers of America (PhRMA) revealed that U.S. hospitals typically charge five times more for medications than their costs.

Read More »

Consumer/Patient Experience Special Feature: Protecting the Patient Experience in the Age of Mega-Mergers

Consolidation has dominated healthcare news over the past few years. Mergers between hospitals, payers, clinics, and other healthcare organizations are turning an ecosystem of individual stakeholders into one dominated by a few giants.

Read More »

Alkermes says long-acting drugs could help schizophrenics stay on medication longer

Alkermes Plc said the company’s long-acting injectable therapy for schizophrenia has helped reduce symptoms and can become an effective option for ensuring patients stay on medication even after being discharged from hospital.

Read More »

Quality of surgical care across a hospital network may vary

Just because the flagship hospital gets good marks for patient care does not mean results will be equally good in affiliated hospitals in the same network, a new study finds.

Read More »

Leaving the hospital early can double the odds of going back

Patients who discharge themselves from the hospital against medical advice are twice as likely to be back within 30 days as those who leave when doctors say they are ready, a large U.S. study finds.

Read More »

Cidara Therapeutics Announces Rezafungin Presentations at the 2019 Transplantation and Cellular Therapy (TCT) Meeting

Cidara Therapeutics Inc. announced that data from studies of the biotechnology company’s lead antifungal rezafungin will be presented at the 2019 Transplantation and Cellular Therapy (TCT) Meeting of ASBMT and CIBMTR to be held in Houston from Feb. 20-24.

Read More »

New York City launches $100 million universal health insurance program

New York City launched a $100 million health insurance program to cover 600,000 uninsured residents, including those unable to afford coverage and those living in the United States illegally.

Read More »

Stocks fall as judge rules Obamacare unconstitutional

Shares of U.S. health insurers, hospitals, and healthcare companies fell after a federal judge ruled that Barack Obama’s signature healthcare law was unconstitutional.

Read More »

FDA staff raises safety issues over Trevena opioid injection

Trevena Inc.’s opioid injection to treat acute pain could be abused and potentially lead to overdose, staff reviewers of the U.S. FDA said, sending the drugmaker’s shares down 66 percent.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!


Ad Right Bottom